ARCHIVES

Final NIH ethics rules retain consulting ban, but limit divesture requirement to senior employees.

This article is from The Cancer Letter archive.

Vol. 31 No. 32 | September 9, 2005

Download PDF Visit The Full Archive

Related Articles

Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer

June 24, 2005

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

January 30, 2009

Scientific, Funding Challenges Test NCI Prevention Effort, Broder Says In First Speech to DCPC Board

February 3, 1989

Phase II Elotuzumab Study Demonstrates 33 Months PFS

July 26, 2013

Ethics Advisory Board to Consider Compensation Issue

September 7, 1979

FDA Roundup: Public Citizen Uses Logic of FDA’s Critical Path to Challenge Decision On Anti-Obesity Drug.

June 9, 2006